Thursday, September 08, 2016
Largest-Ever Study to Compare Medications to Prevent Life-Threatening Clots in Orthopaedic Trauma Patients
Is the blood thinner heparin the most effective option to reduce the risk of blood clots for fracture patients? A comprehensive new study involving 13,000 patients, led by researchers at the University of Maryland School of Medicine (UM SOM), will try to resolve this important question.
Wednesday, September 07, 2016
UM SOM Researchers Discover New Potential Genetic Links to Common Brain Disorder
An international group of researchers has for the first time identified a set of 30 inherited recessive genes that play a role in intellectual disability (ID), a neurodevelopmental disorder that, according to the Centers for Disease Control (CDC), affects as many as 213 million people around the world.
Wednesday, September 07, 2016
Dean Reece to Participate in National Dean's Panel on Critical Issues in Medical Education
Panel Discussion will be live streamed today via Internet. University of Maryland School of Medicine Dean E. Albert Reece, MD, PhD, MBA, will be one of four deans participating in a panel discussion to be held today, September 8, 2016 from 12 noon to 1:30 pm at the University of Florida College of Medicine.
Tuesday, August 30, 2016
New Study Shows Breakthrough Treatment for Essential Tremor Using Focused Ultrasound
University of Maryland School of Medicine (UM SOM) researchers, along with an international group of investigators, have discovered for the first time that treatment with MRI-guided focused ultrasound can effectively treat patients with essential tremor (ET), a neurological movement disorder that affects an estimated 10 million people in the U.S. The results, which are published in the forthcoming issue of the New England Journal of Medicine, led to recent approval of the treatment by the Food & Drug Administration (FDA),
Monday, August 22, 2016
Institute of Human Virology (IHV) Awarded $14.4M for HIV Vaccine Research
The Institute of Human Virology (IHV) announced a $14.4M grant from NIAID to advance HIV vaccine research to solve a major challenge: produce long-lasting antibodies to protect against HIV infection.
Wednesday, August 17, 2016
School of Medicine Graduate Students are Turning a Cancer Test into a Business
Ph.D. students Camilo Vanegas and Elizabeth Weingarter were winners in a competition called the Nanotechnology Startup Challenge in Cancer. Now they are taking a device that detects chronic myeloid leukemia (CML) to market.
Monday, August 08, 2016
University of Maryland Mourns the Passing of Hamish Osborne
University of Maryland School of Medicine faculty and Medical System staff mourn the passing of Hamish S. Osborne. His vision and financial support led to the creation of the Program in Lung Healing, and an endowed professorship in his name.
Thursday, August 04, 2016
UM SOM is Center Stage in Testing National Institutes of Health Zika Vaccine
UM SOM'S Center for Vaccine Development, tapped previously for Ebola vaccine, now steps up to help develop first Zika vaccine.
Tuesday, July 26, 2016
UM SOM Researchers Shed Light on How Neurons Exchange Neurotransmitters
For more than a century, neuroscientists have known that nerve cells talk to one another across the small gaps between them, a process known as synaptic transmission. But the details of how this crucial aspect of brain function occurs have remained elusive. Now, new research has for the first time elucidated details about the architecture that allows brain cells to communicate. The paper was published today in the journal Nature.
Monday, July 25, 2016
UM SOM Launches Unprecedented Initiative to Recruit Scores of Top Scientists
University of Maryland School of Medicine (UM SOM) Dean E. Albert Reece, MD, PhD, MBA, today announced the launch of a bold, new and unprecedented faculty recruitment initiative, Special Trans-Disciplinary Recruitment Award Program (STRAP), designed to attract top scientists to the School, and to significantly catalyze UM SOM’s focus on accelerating discoveries, cures and therapeutics for the most serious diseases that cause morbidity, mortality and disability.